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Abstract
Background: Using the longitudinal Framingham Heart Study data on blood pressure, we analyzed
the reproducibility of linkage measures from serial cross-sectional surveys of a defined population
by performing genome-wide model-free linkage analyses to systolic blood pressure (SBP) and
history of hypertension (HTN) measured at five separate time points.
Results: The heritability of SBP was relatively stable over time, ranging from 11.6 to 23.5%
(coefficient of variation = 25.7%). However, the variability in linkage results was much greater. The
average correlation in LOD scores at any pair of time points was 0.46 for HTN (NPL All LOD) and
0.17 for SBP (Variance Components LOD). No evidence of reproducible linkage results was found,
with a mean κ of 0.02 for linkage to HTN and -0.03 for SBP linkage. At loci with potential evidence
for linkage (LOD > 1.0 at one or more time points), the correlation was even lower. The coefficient
of variation at loci with potential evidence of linkage was 126% for HTN and 135% for SBP. None
of 15 chromosomal regions for HTN and only one of 28 regions for SBP with potential evidence
for linkage had a LOD > 1.0 at more than two of the five time points.
Conclusion: These data suggest that, although heritability estimates at different time points are
relatively robust, the reproducibility of linkage results in serial cross-sectional samples of a
geographically defined population at successive time points is poor. This may explain in part the
difficulty encountered in replicating linkage studies of complex phenotypes.
Background
The inability to replicate linkage findings has been a sig-
nificant limitation in the advancement of understanding
the genetics of complex human diseases [1]. This problem
in reproducibility has been attributed to high false-posi-
tive rates due to the large number of simultaneous
hypotheses being tested in genome screens, to differences
in study design and phenotype definition, genetic hetero-
geneity, or to differences in environmental exposures
affecting gene × environment interactions [2]. In addition,
within a defined population, the strength of linkage to
genes that regulate the rate at which a phenotype changes
over time (i.e., natural history) or that have age-depend-
ent effects may depend on the point in time at which phe-
notypic measurements are made because of changes in the
distribution of ontogenetic stages or ages.
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Although the study of complex disease genetics has thus
far almost exclusively relied on the use of phenotypic data
obtained at a single time point by a cross-sectional study,
it is reasonable to hypothesize that longitudinally col-
lected data may provide more insight into genetic suscep-
tibilities for disease. Methodologies for the analysis of
phenotypic data collected at multiple time points remain
under development. An understanding of the reproduci-
bility of linkage results using phenotypic data measured at
different time points in serial cross-sectional surveys of a
defined population will be important both to our under-
standing of the potential importance of sampling varia-
tion between studies and in developing robust methods
for analyzing longitudinal data. The longitudinal Fram-
ingham Heart Study data made available through GAW13
allows these questions to be directly addressed. In this
paper, we have explored the stability of linkage results to
both a dichotomous and a quantitative trait in serial cross-
sectional samples of a population-based sample in order
to better understand the dependence of analytic results on
sampling error and the particular time at which a sample
is phenotypically assessed.
Methods
The original (parent) cohort had phenotypic data regard-
ing blood pressure collected at 21 time points spaced 2
years apart over 40 years while the offspring cohort was
studied over 20 years at five time points every 4 years apart
except for 8 years between the first two time points. To
generate populations with maximal power, the parent and
offspring cohorts were combined for this analysis. For
each time point at which there were offspring data, phe-
notypic data from the closest date in the parent data set
were used. This resulted in combining the 1971, 1979,
1983, 1987, and 1991 offspring data with the 1972, 1978,
1982, 1986, and 1988 parent data. The traits of interest
were a diagnosis of hypertension (HTN) and systolic
blood pressure (SBP). HTN was defined as systolic blood
pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm
Hg, or use of medical therapy for hypertension. For those
who were receiving antihypertensive medications, the SBP
was assumed to be 10 mm Hg greater than the measured
SBP as data suggest that this is the average reduction seen
with medical therapy [3,4]. This "correction factor" for
SBP has also been found to usefully recover the genetic
information in subjects receiving antihypertensive treat-
ment [5,6].
We used the Whittemore and Halpern NPL (nonparamet-
ric linkage) all statistic to test for allele sharing among all
hypertensive individuals in a pedigree [7]. The Kong and
Cox linear model was used to calculate a nonparametric
LOD score [8]. This process was repeated for each of the
five time points of data collection.
To test for allele sharing using SBP as the quantitative trait
of interest, a variance components model was constructed
for each of the five time points. The total phenotypic var-
iance (conditional on the mean model) was based on a
conventional covariate structure appropriate to the
extended families present in the Framingham cohort. The
model specified was:
σ2
Total = σ2
A + σ2
CS + σ2
C + σ2
E.
In this model, σ2
A represents additive genetic effects, σ2
CS
the effects of common sibling environment, σ2
C the effects
of a common family environment, and σ2
E the residual
variance (which is assumed to arise from nonfamilial fac-
tors). The narrow sense heritability (h2
N) was calculated as
σ2
A / σ2
Total. Age, gender, alcohol use (g/day), smoking
(cigarettes/day), height, weight, and fasting glucose were
included in the model as possible fixed effects. Linkage to
the locus of interest was tested by comparing the likeli-
hood of a model where the variance due to the locus of
interest was constrained to zero versus an unrestricted
model.
The linkage analyses of HTN were undertaken using the
program MERLIN [9]; variance components analyses of
SBP were undertaken in SOLAR [10]. Whole-genome,
multi-point linkage analyses at 1-cM intervals of HTN and
SBP were performed using 394 polymorphic markers on
the 22 autosomes for each time point. Potential evidence
of linkage was defined as LOD > 1.0 at ≥ 1 time point.
Although this threshold does not meet Lander and
Kruglyak's criteria for genome-wide significance [11],
LOD > 1 is commonly used as a measure of promising evi-
dence for linkage in the context of a complex disease [12].
The coefficient of variation (CV) of the heritability over
the five time points was calculated to assess the reproduc-
ibility of this measure of additive genetic effect. To assess
the reproducibility of linkage findings, Spearman correla-
tions of LOD scores between each pair of time points were
calculated over the entire genome as well as over the sub-
set of loci where evidence for potential linkage was
observed. In addition, the CV was calculated at each locus
over the five time points to describe the variability in the
LOD scores for linkage with each of the two traits. Mean
and SD of the CVs at those loci where evidence for poten-
tial linkage was found are reported. The evidence for link-
age was dichotomized at a threshold of LOD = 1.0 and
Cohen's kappa statistic [13] was calculated between each
pair of time points to provide another estimate of the
reproducibility of results.
Results
The characteristics of the population are shown in Table 1.
The sample size decreased over time, with the declineBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S37
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from the first to the last time point amounting to a 27%
reduction. Concomitantly, the variability in SBP rose, as
did the prevalence of HTN. The mean Pearson correlation
for SBP between each pair of time points was 0.69 and the
mean κ for HTN status was 0.55.
As is shown in Table 2, the calculated heritability of SBP
was relatively stable over time, ranging from 11.6% to
23.5% with no clear trend over time. The CV for SBP her-
itability was 25.7%.
The results of the NPL analysis of HTN for the five time
points are displayed in Figure 1. The correlations in LOD
scores between each pair of time points are shown in
Table 3. Overall, the correlation was low to moderate,
with an average correlation of 0.46. As expected, the cor-
relation in linkage evidence decreased with increasing dis-
tance between two time points. The correlation was only
0.03 in the subset of loci where potential evidence of link-
age existed. Using a dichotomous definition of linkage
(LOD ≥ 1 versus LOD < 1), κ statistics for reproducibility
of linkage evidence were also calculated (Table 4). The
average κ was only 0.02, again suggesting poor reproduc-
ibility of linkage. A total of 15 chromosomal regions dis-
played evidence of potential linkage (LOD ≥ 1), with
nearly half of these peaks occurring at the last time point.
Only two of these 15 regions (12p and 17p) had a peak
LOD > 1 at two different time points and no region had
peak LOD > 1 at three or more of the five times. The aver-
age CV in LOD score over these 15 regions was 126%.
The results of the variance components linkage analysis
for SBP are plotted in Figure 2. The correlation matrix
comparing the five time points is given in Table 5. It is
clear that the correlations are poor to nonexistent with a
mean correlation of only 0.17. Among the loci with evi-
dence of potential linkage, the mean correlation was -
0.03. Similarly, the κ statistics displayed in Table 6 dem-
onstrates poor reproducibility of linkage, with a mean
value of only 0.05. A total of 28 chromosomal regions had
LOD > 1 for SBP at one time point. Nine of these 28
regions had evidence of potential linkage at two different
time points and only one region (8p) had a peak LOD > 1
at three of the five times. The mean CV in LOD score over
these 28 regions was 135%.
Discussion
Our findings suggest that although heritability measure-
ments are relatively stable over time, the finding of link-
age to either a quantitative or dichotomous trait using
cross-sectional data is highly dependent on the particular
time point at which phenotypic data is collected. Evidence
for linkage was markedly more labile when potential link-
age (LOD > 1.0) was present on at least one time point.
This may in part be due to regression to the mean but the
poor reproducibility overall suggests other mechanisms
are in play.
Part of the explanation for the high degree of variability in
linkage evidence may be a loss of power as the number of
phenotyped individuals fell with time. However, the loss
was not dramatic and in addition, over half of the
instances of LOD > 1.0 for both traits occurred in the last
Table 1: Population characteristics
Time Point N Mean Age (SE) Mean SBP (SE) (mm 
Hg)
% HTN
1 2563 43.5 (0.35) 127 (0.39) 27.6
2 2131 50.8 (0.35) 128 (0.44) 32.9
3 2027 53.5 (0.34) 130 (0.48) 39.1
4 1968 55.6 (0.34) 132 (0.55) 42.4
5 1868 58.5 (0.34) 132 (0.54) 39.9
Table 2: Heritability and linkage results over time
Time Point
12345
Heritability of SBP (%) 17.9 23.5 11.6 17.7 22.8
No. Regions with LOD > 1.0 for HTN 1 4 2 3 7
No. Regions with LOD > 1.0 for SBP 6 9 6 10 7BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S37
Page 4 of 6
(page number not for citation purposes)
two time points. Alternatively, the lack of reproducibility
may reflect the importance of genes whose effects are
highly dependent on age or on gene × environment
interactions. The disparate results of the linkage analyses
at time points 3 and 4, where the average age is only 2
years apart, the sample sizes are within 3%, and the distri-
bution of SBP and HTN are similar, counter this
argument.
Although there is variability in individual SBP and HTN
assessments in this cohort, the correlations in these
phenotype measures was much stronger than that found
in linkage findings. Importantly, even analyses of highly
NPL-all linkage analyses (MERLIN) of hypertension at five time points Figure 1
NPL-all linkage analyses (MERLIN) of hypertension at five time points.
Table 3: Correlation of HTN LOD scores
Time 
Point
1 2 345
1 1 0.31 0.43 0.28 0.26
2 1 0.66 0.53 0.38
3 1 0.62 0.57
4 1 0.56
51
Table 4: Cohen's kappa for HTN LOD scores
Time 
Point
12345
1 1 0.00 0.00 0.00 -0.01
2 1 0.10 -0.01 -0.01
31 - 0 . 0 1 - 0 . 0 1
41 0 . 1 1
51BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S37
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variable phenotypic measures over time would not neces-
sarily imply poor reproducibility in linkage results so long
as the familial correlations in the measures remain rela-
tively constant (as was suggested by the relative stability of
the heritability estimates for SBP over time).
The changing composition of the population over the five
time points may have also contributed to the variation in
linkage findings. One would expect the correlation to be
greater if the identical population was studied at each time
point. We deliberately did not restrict our analysis to ped-
igrees for which there were data at all time points both
Variance components linkage analyses (SOLAR) of SBP at five time points Figure 2
Variance components linkage analyses (SOLAR) of SBP at five time points. Models adjusted for age, sex, height, 
weight, smoking, and alcohol consumption.
Table 5: Correlation of SBP LOD scores
Time 
Point
12345
1 1 0.10 0.21 0.01 0.17
2 1 0.25 0.41 0.14
3 1 0.27 -0.06
41 0 . 2 1
51
Table 6: Cohen's kappa for SBP LOD scores
Time 
Point
12345
1 1 0.00 -0.02 0.11 0.08
2 1 0.10 0.34 -0.04
3 1 -0.02 0.00
4 1 -0.05
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because this was not the primary hypothesis we wished to
test and because we would have substantially limited our
power to detect linkage. We also believe our approach
more accurately reflects the data that would actually be
available to researchers studying longitudinal popula-
tions. Assuming that the population studied at each time
point is a random sampling of the general population of
the town of Framingham, the linkage results for each
cross-sectional study should represent an unbiased esti-
mate of the true evidence for linkage in the entire
population.
A high degree of lability in complex phenotypic measures
over time together with simple sampling error may be the
most likely explanations for our findings. Stochastic proc-
esses may have a larger influence on complex phenotypes,
and hence on the results of linkage studies, than has been
previously appreciated. The implications of this are dis-
turbing, given than most genetic linkage and association
studies have been based on cross-sectional surveys. It is
possible that phenotypic variability and random error
may be restricted in highly ascertained samples, reducing
this problem. However, in the absence of empirical evi-
dence of this, given the high caliber of the Framingham
Heart Study in terms of both design and quality of pheno-
typing, it is difficult to argue that other studies would be
less subject to this phenomenon. Our results highlight the
difficulty of replicating linkage results for complex
phenotypes and make the need for large longitudinal
studies of such phenotypes clear.
These findings may help to explain the difficulties that
have been experienced in replicating linkage results from
cross-sectional genome scans [1]. Our findings also sug-
gest that further investigations of the lability of linkage
evidence in other conditions are warranted, and highlight
the need for developing robust methods for analyzing
longitudinal data in the context of linkage [14].
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